IESE (España)
-
WeWork´s Failed IPO: What Does the Future Hold for Financing Digital Tranformation
Suárez, José LuisCase F-952-EFinanceWeWork was highly successful in capturing funds through successive rounds of capitalization and expanding its businesses. It was one of the leading workspace proprietors in New York and London. The problem centered on the fact that its losses grew at the same pace as its sales and value in capitalization rounds. The high value of the company set the bar very high for its IPO, to the extent that it didn?t have necessary demand from investors.Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
La fracasada salida a bolsa de WeWork: ¿Cuál es el futuro de la financiación de la transformación digital
Suárez, José LuisCase F-952FinanceWeWork tuvo mucho éxito en la captación de fondos mediante sucesivas rondas de capitalización y en la expansión de sus negocios. Era uno de los principales arrendadores de oficinas en Nueva York y Londres. El problema radicaba en que sus pérdidas crecían al mismo ritmo que sus ventas y su valor en las rondas de capitalización. El elevado valor de la compañía ponía el listón muy alto en la salida a bolsa, tanto que no tuvo la demanda necesaria por...Starting at €8.20
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20